Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

pharmafocus_march_front_cover

March edition of Pharmafocus live

February 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The March 2016 edition of Pharmafocus is now live and available to read here.
News
amgen_ucb

Amgen and UCB announce positive romosozumab results

February 22, 2016 Medical Communications, Research and Development, Sales and Marketing Amgen, Romosozumab, UCB, osteoporosis

Romosozumab development partners Amgen and UCB have announced positive top-line results from a Phase III study of the drug in postmenopausal …
News
sarah_opendi_and_rasha_kelej_at_the_campaigns_launch

Merck launches infertility programme in Uganda

February 22, 2016 Medical Communications, Sales and Marketing Merck Serono

Germany’s Merck has extended its infertility programme ‘Merck More than a Mother’ to Uganda, launching the campaign in a second …
News
novartis_pic

Novartis drug PKC412 gets Breakthrough designation for AML

February 19, 2016 Medical Communications, Research and Development FDA, Novartis, acute myeloid leukaemia

Novartis’ PKC412 (midostaurin)  has become the latest in a sequence of FDA Breakthrough Therapy designations awarded this week- bagging the …
News

More evidence required for Alexion’s Kanuma, says NICE

February 18, 2016 Medical Communications, Research and Development Alexion, Kanuma, LAL-D, rare diseases

NICE says it needs additional trial data before it can recommend Alexion’s enzyme replacement therapy Kanuma (sebelipase alfa) for the …
News
antibiotics

Give GPs feedback on prescribing habits to reduce antibiotic use, says study

February 18, 2016 Medical Communications, Research and Development antimicrobial resistance

A trial of more than 1,500 GP practices has shown that sending general practitioners (GPs) letters giving feedback on their …
News
brexit

What would BREXIT mean for pharma?

February 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing research and development

It began with a promise to UK voters to end ‘benefit tourism’ and to negotiate more flexibility in the UK’s …
Feature
opdivo

UK patients get early access to Opdivo for kidney cancer

February 12, 2016 Medical Communications, Sales and Marketing

Bristol Myers-Squibb’s Opdivo (nivolumab) will be available through the Early Access to Medicines  Scheme (EAMS) as a monotherapy to UK …
News
amgen_flag

Amgen’s Kyprolis now available to UK multiple myeloma patients

February 12, 2016 Medical Communications, Sales and Marketing Amgen, Kyprolis, multiple myeloma

Amgen has announced the UK launch of Kyprolis (carfilzomib) in combination with Revlimid (lenalidomide) and dexamethasone for the treatment of …
News
fda

Biosimilars: Can the US catch up in 2016?

February 12, 2016 Medical Communications, Sales and Marketing Eli Lilly, Enbrel, FDA, Neulasta, Novartis, Pfizer, Sandoz, Zarxio, biosimilars

What are biosimilars? Biosimilars are essentially the biological equivalent of generic drugs to their branded small-molecule counterparts (what Ibuprofen is …
Feature
gsk_good_smaller

GSK fined millions over deals to delay generic competition

February 12, 2016 Medical Communications, Sales and Marketing GSK seroxat

GlaxoSmithKline has been fined £37.6m by the UK Competition & Markets Authority (CMA) for paying two generic drugmakers to delay …
News
sandoz_good

Sandoz buys rights to Pfizer biosimilar

February 12, 2016 Medical Communications, Research and Development, Sales and Marketing Pfiizer, Sandoz, biosimilars

Sandoz has announced further expansion to its biosimilars programme with the acquisition of the European rights to Pfizer’s Remicade (infliximab) …
News
abpi_logo

ABPI appoints Mike Thompson as new chief executive

February 11, 2016 Medical Communications

The Association of the British Pharmaceutical Industry (ABPI) has appointed former GlaxoSmithKline executive Mike Thompson as its new chief executive …
Appointment
carol_lynch

Sandoz’s Carol Lynch elected to chair European Biosimilars Group

February 10, 2016 Medical Communications biosimilars

The European Generic Medicines Association (EGA) has elected Carol Lynch, global head of Biopharmaceuticals & Oncology Injectables at Sandoz, as …
Appointment

NICE publishes new myeloma guidance

February 10, 2016 Medical Communications, Research and Development Farydak, Novartis, multiple myeloma

NICE has set out best practice for the diagnosis, monitoring and treatment of myeloma, in new guidelines published today. Myeloma …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 3, 2026

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026